-
effectivehealthcare-admin.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1406.pdf
June 01, 2014 - dexfenfluramine, now withdrawn from market
because of their association with cardiac valvular fibrosis and pulmonary
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/case-management-future_research.pdf
June 01, 2015 - and outcomes (for
different models of CM)
Note: CM=case management; COPD=chronic obstructive pulmonary
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/machine-learning-quality_research.pdf
September 01, 2012 - Division of Pulmonary and Critical Care, Box 359762, Harborview Medical Center, University of
Washington
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/heart-failure-transition-care_disposition-comments.pdf
May 27, 2014 - in prior RCT, the authors may consider
mentioning biomarkers or devices that measure intracardiac,
pulmonary
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cancer-survivor-care-transition_disposition-comments.pdf
March 18, 2014 - examinations,
screenings, evaluations, and interventions for
musculoskeletal, neurological, cardiovascular
pulmonary
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/infectiousdisease_hi_impact.pdf
December 01, 2013 - of This Intervention
A patient initially presents with symptoms that indicate a possible case of pulmonary
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-2007_research-2007-1.pdf
January 01, 2007 - evaluated losartan versus enalapril
versus amlodipine over 6 months and reported one death due to pulmonary
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/back-pain-treatment_disposition-comments.pdf
February 29, 2016 - examinations, screenings,
evaluations, and interventions for
musculoskeletal, neurological,
cardiovascular, pulmonary
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/09_infectiousdisease_potential_high_impact_june_2012.pdf
January 01, 2012 - Point of This Intervention
A patient initially presents with symptoms that indicate a possible case of pulmonary
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/indirect-comparisons_research.pdf
March 01, 2013 - extended-release oxybutynin
or Tolterodine would present
undue risk (medically
uncontrolled cardiovascular,
pulmonary